MODERN ASPECTS OF SEPTICAL COMPLICATIONS IN CHILDREN WITH MYOLOBLASTIC LEUKOSIS AT THE STAGES OF CHEMIOTHERAPIY
Abstract
The article presents a review of the current literature on the diagnosis and treatment of septic complications at different stages of chemotherapy in children with acute myeloblastic leukemia.
Scientific studies in recent years have proven that due to the increased virulence of infectious agents and resistance to antibacterial drugs, the use of antibiotics has changed, according to the sensitivity of microbes and minimal adverse effects.
About the Authors
I. I. Karayev
State Institution “Republican Scientific and Clinical Center for Pediatrics and Children’s Surgery
Tajikistan
Tajikistan
R. Z. Yuldoshev
SEI Avicenna Tajik State Medical University
Tajikistan
Tajikistan
Yuldoshev Ravshan Zoidovich - Doctor of Medical Sciences, Head of the Department of Oncology and Radial Diagnostics
M. N. Umarova
Tajikistan
N. G. Rakhimov
State Institution “Republican Scientific and Clinical Center for Pediatrics and Children’s Surgery
Tajikistan
Tajikistan
B. R. Rakhimov
SEI National Medical Center of Tajikistan “Shifobakhsh”
Tajikistan
Tajikistan
References
1. Alefirov A. N. Pobochnye effekty khimioterapii v onkologii. Profilaktika i preodolenie pri pomoshchi lekarstvennykh rasteniy: tsikl lektsiy [Side effects of chemotherapy in oncology]. St. Petersburg, 2008. 25 p.
2. Aliev D. A. [Organization of chemotherapeutic treatment of cancer patients]. 6 sezd Onkologov i radiologov stran SNG [VI Congress of Oncologists and Radiologists of CIS countries]. Minsk, 2010, pp. 95. (In Russ.)
3. Balasheva I. I. 50 let kliniko-epidemiologicheskikh issledovaniy ostrykh leykozov u detey Tomskoy oblasti [50 Years of Clinical and Epidemiological Studies of Acute Leukemia in Tomsk Oblast Children]. Sibirskiy onkologicheskiy zhurnal - Siberian Journal of Oncology, 2010, No. 1, pp. 23-28.
4. Beyn B. Dzh. Khronicheskie mieloidnye leykozy: atlas-spravochnik [Chronic Myeloid Leukemia: Atlas Guide]. Moscow, Granat Publ., 2014. 58 p.
5. Boychenko E. G. Rezultaty lecheniya ostrogo limfoblastnogo leykoza u detey v Sankt-Peterburge s ispolzovaniem intensivnoy khimioterapii: retrospektivnaya otsenka effektivnosti dvukh versiy protokola Soall-92 [Results of Pediatric Acute Lymphoblastic Leukemia Treatment in St. Petersburg Using Intensive Chemotherapy: A Retrospective Evaluation of the Effectiveness of Two Versions of the Coall-92 Protocol]. Voprosy sovremennoy pediatrii - Questions of modern pediatrics, 2011, No. 3 (10), pp. 37-46.
6. Analiz infektsionnykh oslozhneniy gemablastozov v Amurskoy oblasti [Analysis of infectious complications of hematoblastosis in the Amur region]. Byulleten fiziologii i patologii dykhaniya - Respiratory Physiology and Pathology Bulletin, 2012, No. 46, pp. 64-68.
7. Belmera S. V. Gastroenterologiya detskogo vozrasta [Pediatric Gastroenterology]. Moscow, MEDPRAKTIKA-M Publ., 2010. 476 p.
8. Ismoilov K. I. Korrektsiya narusheniy gemostaza pri leykoze u detey [Correction of hemostasis disorders in childhood leukemia]. Zdravookhranenie Tadzhikistana – Healthcare of Tajikistan, 2011, No. 3, pp. 45-48.
9. Kadricheva T. G. Funktsionalnaya aktivnost neytrofilnykh granulotsitov u detey s ostrym limfoblastnym leykozom [Functional activity of neutrophil granulocytes in children with acute lymphoblastic leukemia]. Meditsinskaya immunologiya - Medical immunology, 2011, No. 6, pp. 631-634.
10. Karaev I.I. The disorders of the digestive system in children with acute currents lymphoblastic leukosis and their prevention.
11. Kalinina I.I. Rezultaty terapii kandidemii u detey s razlichnymi gematologicheskimi i onkologicheskimi zabolevaniyami v usloviyakh odnogo tsentra [Results of Candidaemia Therapy in Children with Various Hematological and Oncological Diseases in One Center]. Onkogematologiya - Oncohematology, 2011, Vol. 3, pp. 24-34.
12. Keshishyan E. S. Osobennosti formirovaniya mikroflory kishechnika u detey pervogo goda zhizni: novyy probiotik i lineks detskiy pokazaniy k primeneniyu [Peculiarities of formation of intestinal microflora in children of the first year of life: new probiotic and linex pediatric indications]. Praktika pediatrii - Practice of Pediatrics, 2013, No. 4, pp. 51-55.
13. Faktory, vliyayushchie na izlechenie u bolnykh gemoblastozami i kandidemiey [Factors affecting cure in patients with hemoblastosis and candidemia]. Terapevticheskiy arkhiv - Therapeutic archive, 2015, No. 7 (87), pp. 77-87.
14. Klyasova G. A. Detektsiya enterobakteriy s produktsiey beta-laktamaz rasshirennogo spektra u bolnykh ostrymi mieloidnymi leykozami i limfomami pri postuplenii v statsionar [Detection of Enterobacteriaceae with extended-spectrum beta-lactamase production in patients with acute myeloid leukemia and lymphoma on admission to hospital]. Gematologiya i transfuziologiya - Hematology and Transfusiology, 2016, No. 1 (61), pp. 1.
15. Kozlov R. S. Serologicheskaya kharakteristika i chuvstvitelnost k antibiotikam pnevmokokkov, vydelennykh u detey v vozraste do 5 let v otdelnykh regionakh Rossiyskoy Federatsii [Serological characteristics and antibiotic sensitivity of pneumococci isolated in children under 5 years of age in selected regions of the Russian Federation]. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya - Clinical Microbiology and Antimicrobial Chemotherapy, 2011, No. 13 (2), pp. 177-187.
16. Ladodo K. S. Ratsionalnoe pitanie detey rannego vozrasta [Rational nutrition for young children]. Moscow, 2009. 265–272 p.
17. Murodov M. D. Enteralnaya nedostatochnost i ego korrektsii pri ostrom leykoze u detey [Enteral insufficiency and its correction in acute leukemia in children]. Pediatriya i detskaya khirurgiya Tadzhikistana - Pediatrics and Pediatric Surgery of Tajikistan, 2014, No. 2, pp. 31-24.
18. Nabiev Z. N. Profilaktika oslozhneniy posle khimioterapii u detey s leykozom [Prevention of complications after chemotherapy in children with leukemia]. Zdravookhranenie Tadzhikistana – Healthcare of Tajikistan, 2015, No. 4, pp. 14-17.
19. Okhmat V. A. Primenenie antibiotikov pri febrilnoy neytropenii u bolnykh ostrymi leykozami [Antibiotic treatment of febrile neutropenia in acute leukemia patients]. Klinicheskaya onkogematologiya - Clinical oncohematology, 2018, No. 11 (1), pp. 100-109.
20. Parovichnikova E. N. Lechenie bolnykh ostrymi mieloidnymi leykozami po protokolu rossiyskogo mnogotsentrovogo randomizirovannogo issledovaniya OML-01.10: rezultaty koordinatsionnogo tsentra [Treatment of patients with acute myeloid leukemia according to the protocol of the Russian multicenter randomized trial OML-01.10: results of the coordination center]. Terapevticheskiy arkhiv - Therapeutic archive, 2014, No. 86 (7), pp. 14-23.
21. Parovichnikova E. N. Pervye itogi terapii Ph-negativnykh ostrykh limfoblastnykh leykozov vzroslykh po protokolu Nauchno-issledovatelskoy gruppy gematologicheskikh tsentrov Rossii OLL-2009 [First results of treatment of Ph-negative acute lymphoblastic leukemia in adults according to the protocol of the Hematology Research Group of Russia OLL 2009]. Terapevticheskiy arkhiv - Therapeutic archive, 2011, No. 83 (7), pp. 11-17.
22. Savchenko V. G. Natsionalnye klinicheskie rekomendatsii po diagnostike lecheniyu ostrykh mieloidnykh leykozov vzroslykh [National clinical guidelines for the diagnosis and treatment of adult acute myeloid leukemia]. Gematologiya i transfuziologiya - Hematology and Transfusiology, 2014, No. 59 (1), pp. 3-29.
23. Sisla B. Rukovodstvo po laboratornoy gematologii [Руководство по лабораторной гематологии]. Moscow, Prakticheskaya meditsina Publ., 2011. 37-39 p.
24. Strachunskiy L. S. V-laktamazy rasshirennongo spektra-bystro rastushchaya i plokho osoznavaemaya ugroza [Extended-spectrum B-lactamases-a rapidly growing and poorly understood threat]. Klin. mikrobiol. antimikrob. Khimioter - Clinical Microbiology and Antimicrobial Chemotherapy, 2005, No. 1 (7), pp. 92-96.
25. Tadzhibaeva Z. N. Primenenie immunnykh preparatov pri leykoze u detey [Use of immune preparations in children with leukemia]. Pediatriya i detskaya khirurgiya Tadzhikistana - Pediatrics and Pediatric Surgery of Tajikistan, 2012, No. 2, pp. 27-29.
26. Khuseynov Z. Kh. Korrektsiya nutritivnoy nedostatochnosti s ostrym limfoblastnym leykozom u detey [Correction of nutritional deficiency with acute lymphoblastic leukemia in children]. Pediatriya i detskaya khirurgiya Tadzhikistana - Pediatrics and Pediatric Surgery of Tajikistan, 2012, No. 3, pp. 70-73.
27. Khojieva G.B., Rakhmatov M.K., Khasanov J.M., Urakov K.Z. Clinical and hematological features of acute leukemia in Tajikistan.
28. Chesnokova N. P. Leykozy: gematologicheskaya kharakteristika i osobennosti techeniya otdelnykh form ostrykh leykozov [Leukemia: hematological characteristics and peculiarities of the course of certain forms of acute leukemia]. Mezhdunarodnyy zhurnal prikladnykh i fundamentalnykh issledovaniy - International Journal of Applied and Basic Research, 2015, No. 7 (1), pp. 166-169.
29. Al-Ali H. K. The role of hypomethylating agents in the treatment of elderly patients with AML. Journal of genatroncologic, 2014, No. 5 (1), pp. 89- 105.
30. Arai S. Evi-1 is a transcriptional target of MLL oncoproteins in hematopoietic stem cells. Blood, 2011, No. 117 (23), pp. 6304-6314.
31. Assouiine S. A phase I trial of ribavirin and low-dose cytarabine for the treatment of relapsed and refractory acute myeloid leukemia with elevated elF4E. Haematologica, 2015, No. 100 (1), pp. 7-9.
32. Averbuch D. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica, 2013, Vol. 98, No. 12, pp. 1826-1835.
33. Chou Y. L. Bacillus Сereus septicemia in a patient with acute lymphoblastic leukemia: A case report and review of the literature. Journal of Microbiology, Immunology and Infection, 2016, No. 49, pp. 448-451.
34. Dombret H. International phase 3 study of azacitidmevs conventional care regimens in older patients with newly diagnosed AML with > 30% blasts. Blood, 2015, No. 126 (3), pp. 291-299.
35. Jabbour E. Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy. Cancer, 2010, No. 116 (16), pp. 3830-3834.
Review
For citations:
Karayev I.I., Yuldoshev R.Z., Umarova M.N., Rakhimov N.G., Rakhimov B.R. MODERN ASPECTS OF SEPTICAL COMPLICATIONS IN CHILDREN WITH MYOLOBLASTIC LEUKOSIS AT THE STAGES OF CHEMIOTHERAPIY. Health care of Tajikistan. 2021;(1):90-98. (In Russ.)
Views:
347
Email this article 